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EPI Update for Friday, October 16, 2009 
Center for Acute Disease Epidemiology (CADE) 
Iowa Department of Public Health (IDPH) 
  
Items for this week’s EPI Update include: 
 H1N1 Quick Points for the Health Care Provider 
 Update on shortage of erythromycin ointment 
 Laboratory testing of Shiga-toxin producing E. coli infection 
 National health literacy month features six stories from Iowa 
 New CADE staff 
 Meeting announcements and training opportunities 
  
H1N1 Quick Points for the Health Care Providers 
Public health has heard that HCP’s want basic and current “bottom line” 
information about H1N1; thus we have created these weekly “quick points for 
HCPs” to provide the most updated info in a brief and succinct manner. Please 
forward these points on to any other HCP that might find them useful. They will 
be also posted on the IDPH Web site. 
  
 2009 H1N1 and seasonal flu vaccines can be given at any time, in any 
sequence, and in any combination in relation to each other, with one exception: 
when using the nasal spray vaccine for both, they should be separated by 28 
days. www.cdc.gov/h1n1flu/vaccination/public/vaccination_qa_pub.htm 
 
 A recent study showed that surgical masks and N95 respirators had similar 
effectiveness in preventing exposure to influenza. jama.ama-
assn.org/cgi/content/full/2009.1466   
  
 The live nasal spray flu vaccine (both 2009 H1N1 and seasonal flu) can be safely 
given to almost all healthy health care workers less than 50 years of age. (The 
only group of health care workers for whom it is not recommended is health care 
workers who care for immune-compromised patients while they are in specialized 
environments, such as those caring for patients on bone marrow transplant 
hospital wards).  www.cdc.gov/mmwr/preview/mmwrhtml/rr5502a1.htm  
  
 All flu being seen in Iowa as of September 9 is 2009 H1N1. No seasonal flu 
strains have been confirmed yet in Iowa. www.idph.state.ia.us/adper/iisn.asp   
  
 The 2009 H1N1 influenza strain is susceptible to Tamiflu. 
www.cdc.gov/h1n1flu/antiviral.htm  
  
 The average age of Iowa’s hospitalized patients due to 2009 H1N1 is 30. Three 
deaths have occurred in Iowa since September 1: all were adults over 18 years 
of age with risk factors for complications of influenza. 
www.idph.state.ia.us/IdphNews/Archive.aspx   
  
 Children 9 years of age and younger will need to receive two doses of 2009 
H1N1 vaccine, at least 21 days apart, preferably 28 days apart. (Note: different 
from seasonal flu vaccine which is 8 years of age and younger.) 
www.cdc.gov/h1n1flu/vaccination/clinicians_qa.htm 
 
 Correct Information: 2009 H1N1 influenza vaccination is not being mandated by 
public health for anyone in Iowa. Neither seasonal flu vaccine nor 2009 H1N1 
vaccine contains adjuvant. Neither involuntary isolation nor involuntary 
quarantine is being used for 2009 H1N1 in Iowa.  www.idph.state.ia.us/h1n1/  
 
 About 115 million doses of seasonal flu vaccine have been made (more than last 
year’s supply). Approximately 60 percent of that has been distributed. There are  
almost two months left to vaccinate for seasonal flu before it is expected to arrive 
in Iowa, and over three months before it is expected to peak. 
 During the mumps outbreak several years ago (mumps is spread in a similar way 
to influenza), more health care workers caught mumps from co-workers than 
from patients. Sick health care workers should stay home when ill.  
 
 A hotline is available to the public at 800-447-1985. Please provide this number 
to patients who have questions. 
 
 More information on 2009 H1N1 can be found at www.idph.state.ia.us/h1n1, 
and on the locations for Iowa’s 2009 H1N1 vaccine clinic sites at 
www.idph.state.ia.us/webmap/default.asp?map=h1n1_vaccine_sites   
  
Public Heath is providing these quick points to address any questions and 
concerns of Iowa’s health care providers. Please send questions and issues you 
wish to see addressed to influenzaAH1N1@idph.state.ia.us 
  
Update on shortage of erythromycin ophthalmic ointment  
CDC has published guidance at 
www.cdc.gov/std/treatment/2006/erythromycinOintmentShortage.htm describing 
the occurrence of adverse events associated with use of Gentamicin ophthalmic 
ointment. 
  
Laboratory testing of Shiga-toxin producing E. coli infection 
In the 1990s, an outbreak resulting from eating poorly cooked beef from a fast 
food restaurant chain brought E. coli O157 to the nation’s attention. E. coli O157 
and its cousins, other Shiga Toxin producing E. coli (STEC), cause disease by 
the production of Shiga-toxin (serogroups O26, O45, O103, O111, O121, and 
O145) and are reportable in Iowa. However, few non-O157 STEC infections are 
detected in clinical diagnostic laboratories since they do not routinely test stool 
specimens for these organisms 
Clinical diagnostic laboratories should include STEC O157 in their routine 
bacterial enteric panel. If bacterial culture for STEC O157 is not performed in 
parallel with EIA or other rapid method for detection of Shiga toxin, Shiga toxin-
positive broths should be inoculated to a selective isolation medium, such as 
SMAC agar, and any resulting sorbitol-negative colonies should be tested with 
O157 antiserum or latex reagent. All confirmed and presumptive STEC O157 
isolates and Shiga-toxin positive broths that do not yield STEC O157 should be 
forwarded to UHL for confirmatory testing and further genetic characterization. 
From July 1, 2008 through June 30, 2009, UHL has detected 61 O157 isolates, 
and 103 isolates of non-O157 STEC. 
National health literacy month features six stories from Iowa 
About three years ago, Norma Kenoyer had a routine outpatient surgery. 
Afterwards, she was given four pages of information about the operation and told 
to take it easy the rest of the day. The following day, Norma went to work where 
she had to lift some fairly heavy objects.  "The next morning I felt like my insides 
were going to fall out," Norma recalls. "Then my husband read the papers and 
told me I shouldn't have done any lifting so soon after the surgery."   
As someone who has struggled with dyslexia all her life, Norma is one of Iowa's 
strongest advocates for adult literacy, especially health literacy. Norma's story is 
one of six submitted by Iowans to a national project promoting October as 
National Health Literacy Month. In October, one or more new stories will be 
added each day to the project's Web site www.healthliteracymonth.org   
  
New CADE staff 
Barbara Livingston, RN, BSN, MPH, CIC is the Healthcare-Associated Infections 
(HAI) Grant Coordinator. Barbara has had 33 years of health care experience 
and worked extensively with the Department of Veteran Affairs (VHA) to 
implement HAI prevention activities. She has been an active member of the 
Infection Preventionist and Professional Nursing community in Iowa and 
nationally. Barbara can be reached at: 515-242-3892 or blivings@idph.state.ia.us 
  
Christopher Tate is an epidemiologist working with influenza surveillance and 
IDSS.  Chris has a B.A. in Biology with a Biomedical Studies Concentration from 
St. Olaf College and is completing his M.P.H. in Epidemiology from the University 
of Minnesota. He worked for seven years at Fairview Ridges Hospital and spent 
two years at the Minnesota Department of Health as an intern focusing on 
pandemic influenza preparedness and infection control. He also served on 
numerous work groups in the development and publishing of Allocating 
Pandemic Influenza Vaccines in Minnesota and For the Good of Us All: Ethically 
Rationing Health Resources in Minnesota in a Severe Influenza Pandemic.  He 
can be reached at (515) 281-0247 and  ctate@idph.state.ia.us  
  




Have a healthy and happy week! 
Center for Acute Disease Epidemiology 
Iowa Department of Public Health 
800-362-2736 
 
